JOURNAL OF CLINICAL SURGERY ›› 2022, Vol. 30 ›› Issue (4): 345-348.doi: 10.3969/j.issn.1005-6483.2022.04.013

Previous Articles     Next Articles

Decreased expression of hsa-mir-337 predicts poor prognosis in patients with breast cancer

  

  1. Department of Surgery,the First Hospital of Hebei Medical University,Shijiazhuang 061100, China
  • Received:2021-06-23 Accepted:2021-06-23 Online:2022-04-20 Published:2022-04-20

Abstract: Objective To identify the prognostic role of hsa-mir-337 in breast cancer.Methods The TGGA database was used to gain miRNA-seq expression as well as clinical data.R software was used for data analysis.Univariate Cox analysis as well as Multivariate Cox analysis were used to identify the prognostic significance of hsa-mir-337 in BREAST CANCER patients.GSEA was performed to analyze the functional annotation of the predicted genes. Results Hsa-mir-337 was significantly associated with overall survival(OS)of BREAST CANCER.The low expression group had worse OS compared to the high expression group.Through Multivarite analysis with Cox proportional hazards model indicated that hsa-mir-337(HR=0.981062,P<0.001) was independent progonostic factor for patients with breast cancer. Conclusion Hsa-mir-337 was identified as an independent factor in the prognosis of breast cancer.

Key words: breast cancer, hsa-mir-337, the cancer genome atlas, prognosis

[1] YANG Heng, ZHANG Jun, GUO Qiang, et al. The potential value of HLA-DPB1 in lung adenocarcinoma was analyzed based on multi-database [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 339-344.
[2] WANG Pengyuan, SHANG Yichao, ZHENG Duo, et al. Prognostic analysis of pelvis and ureteral carcinoma [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 368-371.
[3] JIN Chenglong, ZHANG Jianguo. Research progress of sentinel lymph node biopsy after neoadjuvant chemotherapy for breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(4): 386-389.
[4] LU Kaijin, SHEN Jiangfeng, JIA Weiguang. Effect of thoracoscopic modified recurrent laryngeal nerve lymph node dissection for esophageal cancer and its effect on patient prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 257-260.
[5] SHEN Jian, LI Minzhe, DU Yanfu. Effect of central obesity on clinical efficacy of laparoscopic D2 radical gastrectomy for distal gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 261-265.
[6] LI Yuzhu, XIA Lianjie. Expression of Dickkopfrelated protein 2 in cancer tissues of patients with bladder cancer and its correlation with prognosis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(3): 280-283.
[7] JI Jintao, KANG Bo, SU Yansheng. Relationship between prostate specific membrane antigen expression and clinicopathological features in prostate cancer patients and its prognostic value [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 130-133.
[8] YUAN Yongxian, YU Jianzhong, WANG Yongxia. Effects of breast cancer cell exosomes miR-27a on the polarization of macrophages and on tumor growth and metastasis [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 149-154.
[9] LI Yunlong, DU Zhenghua, ZHANG Huimin, et al. Clinical treatment and prognostic analysis of gastrointestinal pancreatic neuroendocrine neoplasm [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(2): 166-170.
[10] ZHANG Mingkun, WANG Zhe, YANG Liu, et al.. Analysis of prognostic factors and construction of prognostic models for mucinous breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 44-50.
[11] SUN Zheng, QUE Haifeng, LOU Jian, et al.. Prognostic significance of nutritional risk index in stage Ⅳ gastric cancer [J]. JOURNAL OF CLINICAL SURGERY, 2022, 30(1): 58-61.
[12] ZHOU Bei, FAN Lichun, WU Chenhao, et al.. Expression of TSPAN13 in breast cancer tissues and its correlation with clinicopathological features [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 834-837.
[13] TA NA, WANG Xia, LI Wenjuan, et al.. Relationship between contrast-enhanced ultrasonography and GOLPH3 protein expression in breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 838-841.
[14] LEI Hao, YANG Wenrong, LI Zhonghua.. Effect of OCA2 nucleotide rs4778137 polymorphism on neoadjuvant chemotherapy for triple negative breast cancer [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 842-846.
[15] HU Xinyu, YAO Hui, XIA Dong, et al.. Expression of C3G in gastric cancer tissure and the relation to the clinical features [J]. JOURNAL OF CLINICAL SURGERY, 2021, 29(9): 848-852.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!